tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Silvan Tuerkcan, 136 are a BUY (97.84%), 3 are a HOLD (2.16%).
Analyst Silvan Tuerkcan, currently employed at JMP, carries an average stock price target met ratio of 47.19% that have a potential upside of 50.87% achieved within 127 days.
Silvan Tuerkcan’s has documented 273 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRSP, Crispr Therapeutics AG at 13-Feb-2025.
Analyst best performing recommendations are on LOGC (LOGICBIO THERAPEUTICS).
The best stock recommendation documented was for MRTX (MIRATI THER) at 9/28/2023. The price target of $58 was fulfilled within 7 days with a profit of $12.65 (27.89%) receiving and performance score of 39.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$40
$3.15 (8.55%)
$40
9 days ago
(13-Feb-2025)
4/7 (57.14%)
$5.51 (15.98%)
162
Hold
$29
$-7.85 (-21.30%)
$25
9 days ago
(13-Feb-2025)
6/7 (85.71%)
$-5.49 (-15.92%)
961
Hold
$36
$-0.85 (-2.31%)
$30
10 days ago
(12-Feb-2025)
10/10 (100%)
$3.2 (9.76%)
196
Buy
$45
$8.15 (22.12%)
$31
10 days ago
(12-Feb-2025)
1/2 (50%)
$12.2 (37.20%)
320
Buy
$42
$5.15 (13.98%)
10 days ago
(12-Feb-2025)
12/14 (85.71%)
$9.2 (28.05%)
494
Which stock is Silvan Tuerkcan is most bullish on?
Which stock is Silvan Tuerkcan is most reserved on?
What Year was the first public recommendation made by Silvan Tuerkcan?
